Latest filing published 08 Oct 2025 for Verona Pharma plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Anders Ullman on record concern Verona Pharma plc, in the capacity of senior executive. We count 3 filings; the first trade dates from 4 May 2021 and the latest from 7 October 2025.
On the market, this insider has only sold: 1 sale, €8,426 in total. The rest of the record consists of 1 option exercise.
The record was last updated on 8 October 2025 with a transaction in Verona Pharma plc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations